XML 161 R101.htm IDEA: XBRL DOCUMENT
v3.24.1.u1

Business Combinations (Details) - Frame Pharmaceuticals B.v.Amsterdam Netherlands € / shares in Units, € in Thousands |  | 12 Months Ended |
--- | --- | --- | ---
Jun. 08, 2022 EUR (€) | Dec. 31, 2023 EUR (€) Option shares item Milestone € / shares | Jul. 01, 2022 shares
Business Combinations |  |  |
Amount of fair value | € 32,000 |  |
Net amount of discharging contractual obligations | 1,560 | € 1,560 |
Number of payments in which the total consideration is to be paid | item |  | 3 |
Contingent consideration, Number of payments considered | item |  | 2 |
Issuance and transfer of shares to former Frame shareholders | shares |  | 810,242 |
Value of shares issued to former Frame shareholders |  | € 11,040 |
Closing Share Price | € / shares |  | € 13.63 |
Issuance and transfer of shares as consideration for discharging the contractual obligations for the outstanding advisory agreements | shares |  | 48,254 |
Value of shares issued as consideration for discharging the contractual obligations for the outstanding advisory agreements |  | € 658 |
Cash payments |  | 585 |
Consideration paid in cash for the settlement of the vested employee options |  | 335 |
Additional cash consideration |  | € 250 |
Contingent consideration, Percentage of total consideration |  | 50.00% |
Contingent consideration, Number of milestones | Milestone |  | 2 |
Number of shares issued upon the achievement of the successful investigational new drug application filing | shares |  | 194,644 |
Percentage of consideration transferred upon the achievement of the successful investigational new drug application filing |  | 10.00% |
Value of shares issued upon the achievement of the successful investigational new drug application filing |  | € 1,831 |
Number of shares issued upon successful proof of mechanism in humans | shares |  | 778,575 |
Percentage of consideration transferred upon successful proof of mechanism in humans |  | 40.00% |
Value of shares issued upon successful proof of mechanism in humans |  | € 5,367 |
Contingent consideration, fair value |  | 7,198 |
Total purchase price | € 34,000 | € 19,481 |
Aggregate consideration in shares | shares |  | 858,496 | 858,496
Value of aggregate consideration in shares |  | € 11,697 |
Value of shares issued to former Frame shareholders |  | € 11,697 |
Contingent Consideration, Maximum shares issuable | shares |  | 973,236 |
RSUs issued to certain former employees | Option |  | 89,655 |
Total fair value of the RSU grant |  | € 1,218 |
Number of tranches for vesting of RSUs granted | item |  | 3 |
Transactions costs |  | € 500 |
Provisional fair value |  | 6,216 |
Signing share price representing 10% |  | 32,000 |
Signing share price representing 40% |  | 32,000 |
net deferred tax liability |  | € 20 |

X
- Definition The fair value, at acquisition date, of additional cash transferred as consideration in a business combination. + References No definition available. + Details
Name: | cvac_AdditionalCashTransferred
Namespace Prefix: | cvac_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Amount of cash transferred in a business combination for the settlement of the vested employee options. + References No definition available. + Details
Name: | cvac_CashTransferredForSettlementOfVestedEmployeeOptions
Namespace Prefix: | cvac_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Maximum number of shares issuable as contingent consideration in a business combination. + References No definition available. + Details
Name: | cvac_ContingentConsiderationMaximumSharesIssuable
Namespace Prefix: | cvac_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Number of milestones to be achieved under the contingent consideration arrangement under the business combination. + References No definition available. + Details
Name: | cvac_ContingentConsiderationNumberOfMilestones
Namespace Prefix: | cvac_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | instant

X
- Definition Number of payments of total consideration under the business combination arrangement, that are subject to the achievement of defined milestones (contingent considerations). + References No definition available. + Details
Name: | cvac_ContingentConsiderationNumberOfPaymentsConsidered
Namespace Prefix: | cvac_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | instant

X
- Definition Percentage of total consideration transferred under the business combination, that are subject to the achievement of defined milestones (contingent considerations). + References No definition available. + Details
Name: | cvac_ContingentConsiderationPercentageOfTotalConsideration
Namespace Prefix: | cvac_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition Amount of fair value of total consideration transferred. + References No definition available. + Details
Name: | cvac_FairValueOfTotalConsiderationTransferred
Namespace Prefix: | cvac_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Price of a single share of a number of saleable stocks paid or offered to be paid in a business combination. + References No definition available. + Details
Name: | cvac_IfrsBusinessAcquisitionSharePrice
Namespace Prefix: | cvac_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition The amount recognised as of the acquisition date for deferred tax liabilities net of deferred tax assets assumed in a business combination. + References No definition available. + Details
Name: | cvac_NetDeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate
Namespace Prefix: | cvac_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition The number of instruments or interests issued or issuable at acquisition date for equity interests of the acquirer transferred as consideration for discharging the contractual obligations for the outstanding advisory agreements in a business combination. + References No definition available. + Details
Name: | cvac_NumberOfInstrumentsOrInterestsIssuedOrIssuableAsConsiderationForDischargingContractualObligations
Namespace Prefix: | cvac_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition The number of instruments or interests issued or issuable at acquisition date for equity interests of the acquirer transferred as consideration to former shareholders in a business combination. + References No definition available. + Details
Name: | cvac_NumberOfInstrumentsOrInterestsIssuedOrIssuableAsConsiderationToFormerShareholders
Namespace Prefix: | cvac_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition The number of instruments or interests issued or issuable at acquisition date for equity interests of the acquirer transferred as consideration upon the achievement of first milestone in a business combination. + References No definition available. + Details
Name: | cvac_NumberOfInstrumentsOrInterestsIssuedOrIssuableUponAchievementOfFirstMilestone
Namespace Prefix: | cvac_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition The number of instruments or interests issued or issuable at acquisition date for equity interests of the acquirer transferred as consideration upon the achievement of second milestone in a business combination. + References No definition available. + Details
Name: | cvac_NumberOfInstrumentsOrInterestsIssuedOrIssuableUponAchievementOfSecondMilestone
Namespace Prefix: | cvac_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Number of payments in which the total consideration is to be paid under the business combination. + References No definition available. + Details
Name: | cvac_NumberOfPaymentsInWhichTotalConsiderationIsToBePaid
Namespace Prefix: | cvac_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | instant

X
- Definition The number of tranches for vesting of instruments granted in a share-based payment arrangement. + References No definition available. + Details
Name: | cvac_NumberOfTranchesForVestingOfInstrumentsGrantedInShareBasedPaymentArrangement
Namespace Prefix: | cvac_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- Definition Percentage of total consideration transferred under the business combination, upon the achievement of first milestone. + References No definition available. + Details
Name: | cvac_PercentageOfConsiderationTransferredUponAchievementOfFirstMilestone
Namespace Prefix: | cvac_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition Percentage of total consideration transferred under the business combination, upon the achievement of second milestone. + References No definition available. + Details
Name: | cvac_PercentageOfConsiderationTransferredUponAchievementOfSecondMilestone
Namespace Prefix: | cvac_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition Amount of provisional fair value. + References No definition available. + Details
Name: | cvac_ProvisionalFairValue
Namespace Prefix: | cvac_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Amount represents of signing share price representing 10%. + References No definition available. + Details
Name: | cvac_SigningSharePriceRepresenting10
Namespace Prefix: | cvac_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Amount represents of signing share price representing 40%. + References No definition available. + Details
Name: | cvac_SigningSharePriceRepresenting40
Namespace Prefix: | cvac_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Value of instruments or interests issued or issuable at acquisition date for equity interests of the acquirer transferred as consideration for discharging the contractual obligations for the outstanding advisory agreements in a business combination. + References No definition available. + Details
Name: | cvac_ValueOfInstrumentsOrInterestsIssuedOrIssuableAsConsiderationForDischargingContractualObligations
Namespace Prefix: | cvac_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Value of instruments or interests issued or issuable at acquisition date for equity interests of the acquirer transferred as consideration to former shareholders in a business combination. + References No definition available. + Details
Name: | cvac_ValueOfInstrumentsOrInterestsIssuedOrIssuableAsConsiderationToFormerShareholders
Namespace Prefix: | cvac_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Value of instruments or interests issued or issuable at acquisition date for equity interests of the acquirer transferred as consideration upon the achievement of first milestone in a business combination. + References No definition available. + Details
Name: | cvac_ValueOfInstrumentsOrInterestsIssuedOrIssuableUponAchievementOfFirstMilestone
Namespace Prefix: | cvac_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Value of instruments or interests issued or issuable at acquisition date for equity interests of the acquirer transferred as consideration upon the achievement of second milestone in a business combination. + References No definition available. + Details
Name: | cvac_ValueOfInstrumentsOrInterestsIssuedOrIssuableUponAchievementOfSecondMilestone
Namespace Prefix: | cvac_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition The fair value, at acquisition date, of the consideration transferred in a business combination. [Refer: Business combinations [member]] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 3 -IssueDate 2023-01-01 -Paragraph B64 -Subparagraph f -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2023-en-r&anchor=para_B64_f&doctype=Appendix&subtype=B -URIDate 2023-03-23 + Details
Name: | ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition The amount of acquisition-related costs for transactions recognised separately from the acquisition of assets and the assumption of liabilities in business combinations. [Refer: Business combinations [member]] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 3 -IssueDate 2023-01-01 -Paragraph B64 -Subparagraph m -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2023-en-r&anchor=para_B64_m&doctype=Appendix&subtype=B -URIDate 2023-03-23 + Details
Name: | ifrs-full_AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The fair value, at acquisition date, of cash transferred as consideration in a business combination. [Refer: Business combinations [member]] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 3 -IssueDate 2023-01-01 -Paragraph B64 -Subparagraph f -Clause i -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2023-en-r&anchor=para_B64_f_i&doctype=Appendix&subtype=B -URIDate 2023-03-23 + Details
Name: | ifrs-full_CashTransferred
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition The amount, at acquisition date, of contingent consideration arrangements recognised as consideration transferred in a business combination. [Refer: Business combinations [member]] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 3 -IssueDate 2023-01-01 -Paragraph B64 -Subparagraph g -Clause i -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2023-en-r&anchor=para_B64_g_i&doctype=Appendix&subtype=B -URIDate 2023-03-23 + Details
Name: | ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table. + References No definition available. + Details
Name: | ifrs-full_DisclosureOfBusinessCombinationsLineItems
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The fair value, at the acquisition date, of equity interests of the acquirer transferred as consideration in a business combination. [Refer: Business combinations [member]] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 3 -IssueDate 2023-01-01 -Paragraph B64 -Subparagraph f -Clause iv -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2023-en-r&anchor=para_B64_f_iv&doctype=Appendix&subtype=B -URIDate 2023-03-23 + Details
Name: | ifrs-full_EquityInterestsOfAcquirer
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition The fair value, at acquisition date, of liabilities incurred (for example, a liability for contingent consideration) as consideration transferred in a business combination. [Refer: Business combinations [member]] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 3 -IssueDate 2023-01-01 -Paragraph B64 -Subparagraph f -Clause iii -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2023-en-r&anchor=para_B64_f_iii&doctype=Appendix&subtype=B -URIDate 2023-03-23 + Details
Name: | ifrs-full_LiabilitiesIncurred
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition The number of instruments or interests issued or issuable at acquisition date for equity interests of the acquirer transferred as consideration in a business combination. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 3 -IssueDate 2023-01-01 -Paragraph B64 -Subparagraph f -Clause iv -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2023-en-r&anchor=para_B64_f_iv&doctype=Appendix&subtype=B -URIDate 2023-03-23 + Details
Name: | ifrs-full_NumberOfInstrumentsOrInterestsIssuedOrIssuable
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:decimalItemType
Balance Type: | na
Period Type: | instant

X
- Definition The number of other equity instruments (ie other than share options) granted in a share-based payment arrangement. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name IFRS -Number 2 -IssueDate 2023-01-01 -Paragraph 45 -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_45&doctype=Standard -URIDate 2023-03-23 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 2 -IssueDate 2023-01-01 -Paragraph 47 -Subparagraph b -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_47_b&doctype=Standard -URIDate 2023-03-23 + Details
Name: | ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:decimalItemType
Balance Type: | na
Period Type: | duration

X
- Definition The weighted average fair value at the measurement date of granted equity instruments other than share options. [Refer: Weighted average [member]] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 2 -IssueDate 2023-01-01 -Paragraph 47 -Subparagraph b -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_47_b&doctype=Standard -URIDate 2023-03-23 + Details
Name: | ifrs-full_WeightedAverageFairValueAtMeasurementDateOtherEquityInstrumentsGranted
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Details
Name: | ifrs-full_BusinessCombinationsAxis=cvac_FramePharmaceuticalsB.v.AmsterdamNetherlandsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |